This Reuters summary of a report featured in Clinical Infectious Disease supports the view that a substantial focus on universal opt-out HIV testing as an answer to the problem of HIV-positive individuals receiving care late in the course of their disease may be missing the boat. Dr. Laura A. Cheever states that "in the U.S., it is estimated that only half of those eligible for antiretroviral therapy actually receive it." And Dr. Cheever, of the Health Resources and Services Administration, states: "If we are to improve our response to the HIV epidemic in this country and lessen mortality, we need to place a greater emphasis on engaging and retaining patients in care."
The Center for HIV Law and Policy challenges barriers to the rights and health of people affected by HIV through legal advocacy, high-impact policy initiatives, and creation of cross-issue partnerships, networks, and resources. We support movement building that amplifies the power of individuals and communities to mobilize for change that is rooted in racial, gender, and economic justice.